Unlocking Profitability: Omega Therapeutics Unveils Groundbreaking Preclinical Data on Epigenomic Control of CXCL Genes
Omega Therapeutics Presents New Preclinical Data Demonstrating Coordinated Modulation of Epigenetic Profile CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) — The latest research from Omega Therapeutics showcases the coordinated modulation of the epigenetic profile of CXCL1-8 genes, resulting in the downregulation of gene expression and protein levels. This modulation has been shown to inhibit immune…